Orchestra BioMed Holdings (OBIO) Interest Expenses (2021 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Interest Expenses of $2.7 million for Q1 2026, up 479.87% year-over-year from $462000.0 in Q1 2025, and up 642.11% quarter-over-quarter from $361000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Interest Expenses (2021 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Interest Expenses for 6 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 479.87% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (up 1044.87% YoY), while the FY2025 annual figure was $108.3 million, up 15.29% from the prior year.
- Interest Expenses grew to $2.7 million in Q1 2026 per OBIO's latest filing, from $361000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $8.3 million in Q2 2024 and bottomed at -$579000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $1.8 million across 5 years, with a median of $424500.0 in 2022.
- Annual changes were most pronounced in 2023 — Interest Expenses surged 1836.69% — and 2024, when it tumbled 82.92%.
- Orchestra BioMed Holdings' Interest Expenses stood at $260000.0 in 2022, then jumped by 2782.69% to $7.5 million in 2023, then tumbled by 107.73% to -$579000.0 in 2024, then surged by 162.35% to $361000.0 in 2025, then surged by 642.11% to $2.7 million in 2026.
- Business Quant data shows OBIO's Interest Expenses at $2.7 million in Q1 2026, $361000.0 in Q4 2025, and $225000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Orchestra BioMed Holdings | 265.06 Mn | 80.63 Mn | 63,000.00 | 2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.94 Mn |
| Jun 30, 2026 | 2.94 Mn |
| Mar 31, 2026 | 2.68 Mn |
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 361,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 225,000.00 |
| Sep 30, 2025 | 225,000.00 |
| Jun 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.24 Mn |
| Mar 31, 2025 | 462,000.00 |
| Mar 31, 2025 | 462,000.00 |
| Dec 31, 2024 | -579,000.00 |
| Dec 31, 2024 | -579,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |